The most impressive breakthroughs in clinical research are coming from smart companies that combine data from dozens of studies from around the world into one giant meta-analysis. This Nerac research paper outlines the ways that medical device and pharmaceutical companies can use meta-analyses to investigate safety and efficacy, compare cost effectiveness of one treatment over another, help achieve regulatory approval, justify the expansion of indications for use, and qualify for further grant-funded studies.